scholarly journals Poor sleep correlates with biomarkers of neurodegeneration in mild traumatic brain injury patients: a CENC Study

SLEEP ◽  
2020 ◽  
Author(s):  
J Kent Werner ◽  
Pashtun Shahim ◽  
Josephine U Pucci ◽  
Lai Chen ◽  
Sorana Raiciulescu ◽  
...  

Abstract Study Objectives Sleep disorders affect over half of mild traumatic brain injury (mTBI) patients. Despite evidence linking sleep and neurodegeneration, longitudinal TBI-related dementia studies have not considered sleep. We hypothesized that poor sleepers with mTBI would have elevated markers of neurodegeneration and lower cognitive function compared to mTBI good sleepers and controls. Our objective was to compare biomarkers of neurodegeneration and cognitive function with sleep quality in warfighters with chronic mTBI. Methods In an observational warfighters cohort (n=138 mTBI, 44 controls), the Pittsburgh Sleep Quality Index (PSQI) was compared with plasma biomarkers of neurodegeneration and cognitive scores collected an average of 8 years after injury. Results In the mTBI cohort, poor sleepers (PSQI≥10, n = 86) had elevated plasma neurofilament light (NfL, x̅ = 11.86 vs. 7.91 pg/mL, p=0.0007, d=0.63) and lower executive function scores by the categorical fluency (x̅ = 18.0 vs 21.0, p=0.0005, d= -0.65) and stop-go tests (x̅ = 30.1 vs 31.1, p=0.024, d = -0.37). These findings were not observed in controls (n = 44). PSQI predicted NfL (Beta=0.22, p=0.00002) and tau (Beta=0.14, p=0.007), but not amyloid β42. Poor sleepers showed higher obstructive sleep apnea (OSA) risk by STOP-BANG scores (x̅ = 3.8 vs 2.7, p=0.0005), raising the possibility that the PSQI might be partly secondary to OSA. Conclusions Poor sleep is linked to neurodegeneration and select measures of executive function in mTBI patients. This supports implementation of validated sleep measures in longitudinal studies investigating pathobiological mechanisms of TBI related neurodegeneration, which could have therapeutic implications.

2021 ◽  
Author(s):  
Dora M. Zalai

Background and Rationale: Insomnia symptoms following mild traumatic brain injury (mTBI) predict poor TBI outcomes. Insomnia symptoms may be caused by sleep disorders that can be effectively treated, which in turn, may improve mTBI outcomes. Previous studies have focused on insomnia symptom assessment in mTBI or evaluated samples with all TBI severities. To effectively manage insomnia following mTBI, it is important to understand which sleep disorders contribute to insomnia symptoms in this clinical group. Furthermore, it is important to extend research on primary insomnia to determine which variables are related to the perception of poor sleep among individuals who report new onset/worsening insomnia symptoms following mTBI. Objectives: (1) determine the prevalence of sleep disorders that contribute to chronic insomnia symptoms in patients with mTBI and (2) determine which objectively measured electroencephalographic and subjective variables are associated with subjective wake time and the perception of poor sleep among patients with chronic insomnia symptoms following mTBI. Methods: Individuals with chronic insomnia symptoms following mTBI (N = 50; age 17-65; 64% females; 3 - 24 months post mTBI) participated in a multi-method sleep and circadian assessment. Sleep disorders were diagnosed according to ICSD-3 criteria. Results: Insomnia disorder was the most common diagnosis (62%), followed by obstructive sleep apnea (OSA) -44%; circadian rhythm sleep-wake disorders (CRSWD) - 26% and periodic limb movement disorder (PLMD) - 8%. The overestimation of wake time was similar to what has been described in primary insomnia. In contrast to the REM instability hypothesis of primary insomnia, REM sleep duration was not related to subjective wake time. Both low sleep quality and feeling unrested in the morning had the strongest relationship to subjective wake time. Feeling unrested was also associated with anxiety. Conclusions: OSA and CRSWD frequently occur among patients whose main presenting sleep symptom is chronic insomnia following a mTBI. Accordingly, objective sleep and circadian assessment should be part of chronic insomnia evaluation following a mTBI. The results imply that interventions reducing subjective wake time and anxiety could improve subjective sleep quality; however, these interventions should be mplemented in conjunction with the treatment for OSA, CRSWD and PLMD.


2021 ◽  
Author(s):  
Dora M. Zalai

Background and Rationale: Insomnia symptoms following mild traumatic brain injury (mTBI) predict poor TBI outcomes. Insomnia symptoms may be caused by sleep disorders that can be effectively treated, which in turn, may improve mTBI outcomes. Previous studies have focused on insomnia symptom assessment in mTBI or evaluated samples with all TBI severities. To effectively manage insomnia following mTBI, it is important to understand which sleep disorders contribute to insomnia symptoms in this clinical group. Furthermore, it is important to extend research on primary insomnia to determine which variables are related to the perception of poor sleep among individuals who report new onset/worsening insomnia symptoms following mTBI. Objectives: (1) determine the prevalence of sleep disorders that contribute to chronic insomnia symptoms in patients with mTBI and (2) determine which objectively measured electroencephalographic and subjective variables are associated with subjective wake time and the perception of poor sleep among patients with chronic insomnia symptoms following mTBI. Methods: Individuals with chronic insomnia symptoms following mTBI (N = 50; age 17-65; 64% females; 3 - 24 months post mTBI) participated in a multi-method sleep and circadian assessment. Sleep disorders were diagnosed according to ICSD-3 criteria. Results: Insomnia disorder was the most common diagnosis (62%), followed by obstructive sleep apnea (OSA) -44%; circadian rhythm sleep-wake disorders (CRSWD) - 26% and periodic limb movement disorder (PLMD) - 8%. The overestimation of wake time was similar to what has been described in primary insomnia. In contrast to the REM instability hypothesis of primary insomnia, REM sleep duration was not related to subjective wake time. Both low sleep quality and feeling unrested in the morning had the strongest relationship to subjective wake time. Feeling unrested was also associated with anxiety. Conclusions: OSA and CRSWD frequently occur among patients whose main presenting sleep symptom is chronic insomnia following a mTBI. Accordingly, objective sleep and circadian assessment should be part of chronic insomnia evaluation following a mTBI. The results imply that interventions reducing subjective wake time and anxiety could improve subjective sleep quality; however, these interventions should be mplemented in conjunction with the treatment for OSA, CRSWD and PLMD.


2021 ◽  
Vol 11 (11) ◽  
pp. 1369
Author(s):  
Hon-Ping Ma ◽  
Ju-Chi Ou ◽  
Kai-Yun Chen ◽  
Kuo-Hsing Liao ◽  
Shuo-Jhen Kang ◽  
...  

To identify a screening tool for poor self-reported sleep quality at 12 weeks according to non-invasive measurements and patients’ characteristics in the first week after mild traumatic brain injury (mTBI), data from 473 mTBI participants were collected and follow-ups were performed at 12 weeks. Patients with previous poor self-reported sleep quality prior to the injury were excluded. Patients were then divided into two groups at 12 weeks according to the Pittsburgh Sleep Quality Index based on whether or not they experienced poor sleep quality. The analysis was performed on personal profiles and heart rate variability (HRV) for 1 week. After analyzing the non-invasive measurements and characteristics of mTBI patients who did not complain of poor sleep quality, several factors were found to be relevant to the delayed onset of poor sleep quality, including age, gender, and HRV measurements. The HRV–age–gender (HAG) index was proposed and found to have 100% sensitivity (cut-off, 7; specificity, 0.537) to predicting whether the patient will experience poor sleep quality after mTBI at the 12-week follow-up. The HAG index helps us to identify patients with mTBI who have no sleep quality complaints but are prone to developing poor self-reported sleep quality. Additional interventions to improve sleep quality would be important for these particular patients in the future.


2021 ◽  
Vol 341 ◽  
pp. 113698
Author(s):  
William T. O'Brien ◽  
Louise Pham ◽  
Rhys D. Brady ◽  
Jesse Bain ◽  
Glenn R. Yamakawa ◽  
...  

2019 ◽  
Vol 36 (10) ◽  
pp. 1551-1560 ◽  
Author(s):  
Iftakher Hossain ◽  
Mehrbod Mohammadian ◽  
Riikka S.K. Takala ◽  
Olli Tenovuo ◽  
Linnéa Lagerstedt ◽  
...  

BMJ ◽  
2013 ◽  
Vol 346 (mar11 1) ◽  
pp. f723-f723 ◽  
Author(s):  
A. Nordstrom ◽  
B. B. Edin ◽  
S. Lindstrom ◽  
P. Nordstrom

SLEEP ◽  
2020 ◽  
Vol 43 (Supplement_1) ◽  
pp. A159-A159
Author(s):  
K Werner ◽  
P Shahim ◽  
J Gill ◽  
R Nakase-Richardson ◽  
K Kenney

Abstract Introduction Increasing evidence links neurodegeneration to traumatic brain injury (TBI), and a separate body of literature links neurodegeneration to sleep dysfunction, implicating increased toxin production and decreased glymphatic clearance. Sleep disorders affect 50% of TBI patients, yet the sleep-neurodegeneration connection in these patients remains unexplored. We hypothesized that warfighters with TBI and sleep dysfunction would have increased neuronal injury, revealing potential mechanistic underpinnings for TBI outcomes. We measured plasma biomarkers, cognitive function and sleep surveys for correlation analysis. Methods In a retrospective cross-sectional study of warfighters (n=113 chronic mild TBI patients), the Pittsburgh sleep quality index (PSQI) was compared with amyloid β42 (Aβ42), neurofilament light (NFL), tau, and phospho-tau (threonine 181) isolated from plasma and exosomes. Executive function was tested with the categorical fluency test. Exosomes were precipitated from plasma. Proteins were measured with the Single Molecule Array (Quanterix). Linear models were adjusted for age, ApoE, and number of TBIs. Results Poor sleepers with TBI (PSQI>8) had elevated NFL compared to good sleepers in plasma (p=0.007) and exosomes (p=0.00017), and PSQI directly correlated with NFL (plasma: Beta=0.23, p=0.0079; exosomes: Beta=2.19, p=0.0013) stronger than any other marker of neurodegeneration. Poor sleepers also showed higher obstructive sleep apnea (OSA) risk compared to good sleepers by STOP-BANG scores (3.6, SD=1.6 vs 2.8, SD=1.74; p=0.0014) as well as decreased categorical fluency (20.7, SD=4.1) (18.3, SD=4.6, p=.0067). Plasma tau and Aβ42 also correlated with PSQI (Beta=0.64, p=0.028, and Beta=0.40, p=0.049 respectively). Conclusion This is the first reported data correlating markers of neuronal injury and cognitive deficits with sleep complaints and OSA risk in patients with TBI - possibly identifying treatable pathophysiological mediators of TBI neurodegeneration. Limitations include a small sample size, lack of objective sleep measures, and inability to establish directionality due to cross-sectional design. Prospective trials will be required to further explore our proposed hypothesis. If confirmed, these findings would call for targeting sleep disorders in the TBI population to mitigate risk of neurodegeneration. Support This work was supported by grant funding from: Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095 and Department of Veterans Affairs CENC Award I01 CX001135.


Sign in / Sign up

Export Citation Format

Share Document